EMCURE
Emcure Pharmaceuticals Limited
Pharmaceuticals · ₹34,290 Cr market cap
A global pharmaceutical manufacturer established in 1981, Emcure Pharmaceuticals produces and markets a comprehensive range of drug formulations across multiple therapeutic areas for domestic and international markets. The company operates manufacturing facilities that serve patients globally, focusing on both generic and specialty pharmaceutical products. Emcure's diversified operations and geographic presence establish it as a significant player in the pharmaceutical industry.
0
Tracked investors holding
11
Tracked moves
₹1,810
Share price
Latest activity
Morgan StanleyNew position
Morgan Stanley bought 1,37,590 shares of Emcure Pharmaceuticals for ₹25.00 Cr at ₹1817.00 apiece in a block deal. This transaction occurred on June 25, 2026.
Track smart money in Emcure Pharmaceuticals Limited
Get alerted when a top investor buys or sells.
Get started